123 related articles for article (PubMed ID: 12377009)
1. In silico studies toward the discovery of new anti-HIV nucleoside compounds with the use of TOPS-MODE and 2D/3D connectivity indices. 1. Pyrimidyl derivatives.
Estrada E; Vilar S; Uriarte E; Gutierrez Y
J Chem Inf Comput Sci; 2002; 42(5):1194-203. PubMed ID: 12377009
[TBL] [Abstract][Full Text] [Related]
2. In silico studies toward the discovery of new anti-HIV nucleoside compounds through the use of TOPS-MODE and 2D/3D connectivity indices. 2. Purine derivatives.
Vilar S; Estrada E; Uriarte E; Santana L; Gutierrez Y
J Chem Inf Model; 2005; 45(2):502-14. PubMed ID: 15807516
[TBL] [Abstract][Full Text] [Related]
3. Probing the anticancer activity of nucleoside analogues: a QSAR model approach using an internally consistent training set.
Helguera AM; Rodríguez-Borges JE; García-Mera X; Fernández F; Cordeiro MN
J Med Chem; 2007 Apr; 50(7):1537-45. PubMed ID: 17341060
[TBL] [Abstract][Full Text] [Related]
4. Linear indices of the "molecular pseudograph's atom adjacency matrix": definition, significance-interpretation, and application to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors.
Marrero-Ponce Y
J Chem Inf Comput Sci; 2004; 44(6):2010-26. PubMed ID: 15554670
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR analysis of a series of S-DABO derivatives as anti-HIV agents by CoMFA and CoMSIA.
Xu HR; Fu L; Zhan P; Liu XY
SAR QSAR Environ Res; 2016 Dec; 27(12):999-1014. PubMed ID: 27667445
[TBL] [Abstract][Full Text] [Related]
6. QSAR for anti-RNA-virus activity, synthesis, and assay of anti-RSV carbonucleosides given a unified representation of spectral moments, quadratic, and topologic indices.
González-Díaz H; Cruz-Monteagudo M; Viña D; Santana L; Uriarte E; De Clercq E
Bioorg Med Chem Lett; 2005 Mar; 15(6):1651-7. PubMed ID: 15745816
[TBL] [Abstract][Full Text] [Related]
7. Computer-aided molecular design of highly potent HIV-1 RT inhibitors: 3D QSAR and molecular docking studies of efavirenz derivatives.
Pungpo P; Saparpakorn P; Wolschann P; Hannongbua S
SAR QSAR Environ Res; 2006 Aug; 17(4):353-70. PubMed ID: 16920659
[TBL] [Abstract][Full Text] [Related]
8. Trends in the design of nucleoside analogues as anti-HIV drugs.
el Kouni MH
Curr Pharm Des; 2002; 8(8):581-93. PubMed ID: 11945160
[TBL] [Abstract][Full Text] [Related]
9. Novel anti-HIV cyclotriazadisulfonamide derivatives as modeled by ligand- and receptor-based approaches.
Pinheiro JR; Bitencourt M; da Cunha EF; Ramalho TC; Freitas MP
Bioorg Med Chem; 2008 Feb; 16(4):1683-90. PubMed ID: 18053727
[TBL] [Abstract][Full Text] [Related]
10. Predicting anti-HIV activity of dimethylaminopyridin-2-ones: computational approach using topochemical descriptors.
Dureja H; Madan AK
Chem Biol Drug Des; 2009 Feb; 73(2):258-70. PubMed ID: 19207429
[TBL] [Abstract][Full Text] [Related]
11. TOPS-MODE based QSARs derived from heterogeneous series of compounds. Applications to the design of new anti-inflammatory compounds.
Pérez González M; Dias LC; Helguera AM; Rodríguez YM; de Oliveira LG; Gomez LT; Diaz HG
Bioorg Med Chem; 2004 Aug; 12(16):4467-75. PubMed ID: 15265497
[TBL] [Abstract][Full Text] [Related]
12. A ligand-based approach for the in silico discovery of multi-target inhibitors for proteins associated with HIV infection.
Speck-Planche A; Kleandrova VV; Luan F; Cordeiro MN
Mol Biosyst; 2012 Aug; 8(8):2188-96. PubMed ID: 22688327
[TBL] [Abstract][Full Text] [Related]
13. TOPS-MODE based QSARs derived from heterogeneous series of compounds. Applications to the design of new herbicides.
Pérez González M; Gonzalez Díaz H; Molina Ruiz R; Cabrera MA; Ramos de Armas R
J Chem Inf Comput Sci; 2003; 43(4):1192-9. PubMed ID: 12870911
[TBL] [Abstract][Full Text] [Related]
14. Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide derivatives.
Ragno R; Artico M; De Martino G; La Regina G; Coluccia A; Di Pasquali A; Silvestri R
J Med Chem; 2005 Jan; 48(1):213-23. PubMed ID: 15634015
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and anti-HIV activity of novel quinoxaline derivatives.
Patel SB; Patel BD; Pannecouque C; Bhatt HG
Eur J Med Chem; 2016 Jul; 117():230-40. PubMed ID: 27105027
[TBL] [Abstract][Full Text] [Related]
16. QSAR study and VolSurf characterization of anti-HIV quinolone library.
Filipponi E; Cruciani G; Tabarrini O; Cecchetti V; Fravolini A
J Comput Aided Mol Des; 2001 Mar; 15(3):203-17. PubMed ID: 11289075
[TBL] [Abstract][Full Text] [Related]
17. Bis(benzoyloxybenzyl)-DiPPro nucleoside diphosphates of anti-HIV active nucleoside analogues.
Weinschenk L; Gollnest T; Schols D; Balzarini J; Meier C
ChemMedChem; 2015 May; 10(5):891-900. PubMed ID: 25847660
[TBL] [Abstract][Full Text] [Related]
18. 3D connectivity indices in QSPR/QSAR studies.
Estrada E; Molina E
J Chem Inf Comput Sci; 2001; 41(3):791-7. PubMed ID: 11410059
[TBL] [Abstract][Full Text] [Related]
19. QSAR and Pharmacophore Mapping Studies on Benzothiazinimines to Relate their Structural Features with anti-HIV Activity.
Geethaavacini G; Poh GP; Yan LY; Deepashini R; Shalini S; Harish R; Sureshkumar K; Ravichandran V
Med Chem; 2018; 14(7):733-740. PubMed ID: 29807521
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 3'-halo-5'-norcarbocyclic nucleoside phosphonates as potent anti-HIV agents.
Hamon N; Kaci M; Uttaro JP; Périgaud C; Mathé C
Eur J Med Chem; 2018 Apr; 150():642-654. PubMed ID: 29558735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
